Download
11764_2023_Article_1425.pdf 602,21KB
WeightNameValue
1000 Titel
  • Identifying and understanding how people living with a lower-grade glioma engage in self-management
1000 Autor/in
  1. Rimmer, Ben |
  2. Balla, Michelle |
  3. Dutton, Lizzie |
  4. Lewis, Joanne |
  5. Brown, Morven C. |
  6. Burns, Richéal |
  7. Gallagher, Pamela |
  8. Williams, Sophie |
  9. Araújo-Soares, Vera |
  10. Finch, Tracy |
  11. Menger, Fiona |
  12. Sharp, Linda |
  13. on behalf of the Ways Ahead study team |
1000 Verlag Springer US
1000 Erscheinungsjahr 2023
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2023-07-14
1000 Erschienen in
1000 Quellenangabe
  • 18(6):1837-1850
1000 Copyrightjahr
  • 2023
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11764-023-01425-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502583/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract </jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Lower-grade gliomas (LGG) are mostly diagnosed in working-aged adults and rarely cured. LGG patients may face chronic impairments (e.g. fatigue, cognitive deficits). Self-management can improve clinical and psychosocial outcomes, yet how LGG patients self-manage the consequences of their tumour and its treatment is not fully understood. This study, therefore, aimed to identify and understand how LGG patients engage in the self-management of their condition.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>A diverse group of 28 LGG patients (age range 22–69 years; male <jats:italic>n</jats:italic> = 16, female <jats:italic>n</jats:italic> = 12; mean time since diagnosis = 8.7 years) who had completed primary treatment, were recruited from across the United Kingdom. Semi-structured interviews were conducted. Informed by a self-management strategy framework developed in cancer, directed content analysis identified and categorised self-management types and strategies used by patients.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Overall, 20 self-management strategy types, comprising 123 self-management strategies were reported; each participant detailed extensive engagement in self-management. The most used strategy types were ‘using support’ (<jats:italic>n</jats:italic> = 28), ‘creating a healthy environment’ (<jats:italic>n</jats:italic> = 28), ‘meaning making’ (<jats:italic>n</jats:italic> = 27), and ‘self-monitoring’ (<jats:italic>n</jats:italic> = 27). The most used strategies were ‘accepting the tumour and its consequences’ (<jats:italic>n</jats:italic> = 26), ‘receiving support from friends (<jats:italic>n</jats:italic> = 24) and family’ (<jats:italic>n</jats:italic> = 24), and ‘reinterpreting negative consequences’ (<jats:italic>n</jats:italic> = 24).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>This study provides a comprehensive understanding of the strategies used by LGG patients to self-manage their health and wellbeing, with a diverse, and substantial number of self-management strategies reported.</jats:p> </jats:sec><jats:sec> <jats:title>Implications for Cancer Survivors</jats:title> <jats:p>The findings will inform the development of a supported self-management intervention for LGG patients, which will be novel for this patient group. </jats:p> </jats:sec>
1000 Sacherschließung
lokal Cancer Survivors/psychology [MeSH]
lokal Female [MeSH]
lokal Qualitative
lokal Neoplasm Grading [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Middle Aged [MeSH]
lokal Glioma/pathology [MeSH]
lokal Article
lokal Self Care [MeSH]
lokal Qualitative Research [MeSH]
lokal Male [MeSH]
lokal Lower-grade glioma
lokal Quality of Life [MeSH]
lokal Brain Neoplasms/psychology [MeSH]
lokal United Kingdom [MeSH]
lokal Young Adult [MeSH]
lokal Glioma/psychology [MeSH]
lokal Self-Management [MeSH]
lokal Self-management
lokal Brain Neoplasms/therapy [MeSH]
lokal Glioma/therapy [MeSH]
lokal Wellbeing
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UmltbWVyLCBCZW4=|https://frl.publisso.de/adhoc/uri/QmFsbGEsIE1pY2hlbGxl|https://frl.publisso.de/adhoc/uri/RHV0dG9uLCBMaXp6aWU=|https://frl.publisso.de/adhoc/uri/TGV3aXMsIEpvYW5uZQ==|https://frl.publisso.de/adhoc/uri/QnJvd24sIE1vcnZlbiBDLg==|https://frl.publisso.de/adhoc/uri/QnVybnMsIFJpY2jDqWFs|https://frl.publisso.de/adhoc/uri/R2FsbGFnaGVyLCBQYW1lbGE=|https://frl.publisso.de/adhoc/uri/V2lsbGlhbXMsIFNvcGhpZQ==|https://frl.publisso.de/adhoc/uri/QXJhw7pqby1Tb2FyZXMsIFZlcmE=|https://frl.publisso.de/adhoc/uri/RmluY2gsIFRyYWN5|https://frl.publisso.de/adhoc/uri/TWVuZ2VyLCBGaW9uYQ==|https://frl.publisso.de/adhoc/uri/U2hhcnAsIExpbmRh|https://frl.publisso.de/adhoc/uri/b24gYmVoYWxmIG9mIHRoZSBXYXlzIEFoZWFkIHN0dWR5IHRlYW0=
1000 Hinweis
  • DeepGreen-ID: 13df2f6784b049ecacb24b7db57928f9 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Brain Tumour Charity |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Brain Tumour Charity |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6496241.rdf
1000 Erstellt am 2025-02-04T13:03:23.069+0100
1000 Erstellt von 322
1000 beschreibt frl:6496241
1000 Zuletzt bearbeitet 2025-09-13T12:19:16.429+0200
1000 Objekt bearb. Sat Sep 13 12:19:16 CEST 2025
1000 Vgl. frl:6496241
1000 Oai Id
  1. oai:frl.publisso.de:frl:6496241 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source